Key result
Subcutaneous S-ICD implantation linked to ~8-Ω higher late impedance than intermuscular techniques.
Why the study?
Whether longitudinal low-voltage impedance measurements after S-ICD implantation differ across contemporary implantation strategies, and whether these differences are explained by quantitative radiographic geometry beyond categorical PRAETORIAN risk classification, remained incompletely characterized.
Does S-ICD implantation technique (intermuscular vs. subcutaneous) and continuous radiographic implant geometry affect longitudinal low-voltage impedance trajectories in adults receiving an S-ICD?
Cohort (n=136)
No
Does S-ICD implantation technique (intermuscular vs. subcutaneous) and continuous radiographic implant geometry affect longitudinal low-voltage impedance trajectories in adults receiving an S-ICD?
Intermuscular S-ICD implantation techniques achieve lower longitudinal low-voltage impedance over 2 to 5 years compared to subcutaneous implantation, and continuous coil–sternum distance predicts chronic impedance even within the low-risk PRAETORIAN category.
Answers are grounded in this paper and cite their sources.
Subcutaneous S-ICD placement was associated with higher impedance trajectories; leaves open whether technique modification improves defibrillation outcomes.
Background Defibrillation efficacy of the subcutaneous implantable cardioverter‐defibrillator (S‐ICD) depends on shock vector geometry and tissue impedances influenced by implantation technique. Whether longitudinal low‐voltage impedance (LVI) measurements differ across contemporary implantation strategies, and whether these differences are explained by quantitative radiographic geometry, remains incompletely characterized. Objective To determine whether S‐ICD implantation technique is associated with longitudinal LVI trajectories and whether continuous radiographic implant geometry provides information beyond categorical PRAETORIAN risk classification. Methods We performed a single‐center retrospective cohort study of 136 adults receiving an S‐ICD between 2014 and 2024, classified by operative documentation as subcutaneous (SC; n = 27), fluoroscopy‐marked intermuscular (FIM; n = 73), or fluoroscopy‐marked ultrasound‐guided intermuscular (FUSIM; n = 36) techniques. Per‐device LVI was summarized overall and across prespecified windows (0–30 days, 6 months–1 year, 2–5 years). Technique differences were analyzed. We fit a prespecified mixed‐effects interaction model that included coil–sternum distance, scaled in 5 mm increments, and assessed correlations between LVI and radiographic measures. Results In paired analyses, LVI increased by a mean of 13.3 Ω between the 0–30‐day and 2–5‐year windows. Overall LVI differed by implantation technique (Kruskal–Wallis p = 0.019), driven by higher values in SC versus FIM (Holm‐adjusted p = 0.041) and FUSIM ( p = 0.022). Additional impedance differences across techniques were absent in the 0–30‐day window but emerged during follow‐up. In the prespecified interaction mixed‐effects model, SC exhibited a significant additional rise relative to FUSIM during the 2–5‐year window (interaction β = 7.82 Ω, 95% CI 0.98−14.67; p = 0.025). Greater coil–sternum distance was independently associated with higher LVI (13.6 Ω per cm, 95% CI 4.2–23.0; p = 0.005) and correlated with chronic LVI ( n = 76; r = 0.441; Benjamini–Hochberg q < 0.001). The PRAETORIAN score was computable in 76 devices and classified 84% as low risk; within that low‐risk stratum, coil–sternum distance remained associated with chronic LVI ( ρ = 0.320, p = 0.010) whereas the score did not ( ρ = 0.136, p = 0.282), and each 5 mm of coil–sternum distance corresponded to 10.7 Ω higher LVI after adjustment for BMI (95% CI 2.68−18.73, p = 0.010). High‐voltage shock impedance at implant correlated strongly with chronic LVI ( n = 99; r = 0.71, p < 0.001), and the association persisted over 2–5 years ( n = 69; r = 0.61, p < 0.001). Conclusion Longitudinal LVI varies with S‐ICD implantation strategy, with time‐dependent divergence between SC and intermuscular implants. Within the low‐risk PRAETORIAN category, where the categorical score has no dynamic range, continuously measured coil–sternum distance remains associated with chronic impedance. Continuous implant geometry and longitudinal impedance complement, rather than replace, radiographic scoring of implant position.
No takes yet. Share an insight, caveat, or question.
Sanchis‐Gomar et al. (2026) conducted a cohort in Subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation (n=136). Subcutaneous (SC) S-ICD implantation technique vs. Fluoroscopy-marked intermuscular (FIM) and fluoroscopy-marked ultrasound-guided intermuscular (FUSIM) S-ICD implantation techniques was evaluated on Longitudinal low-voltage impedance (LVI) (interaction β = 7.82 Ω (SC vs FUSIM at 2-5 years), 95% CI 0.98-14.67, p=0.019 (overall Kruskal-Wallis); 0.025 (SC vs FUSIM interaction at 2-5 years)). Subcutaneous S-ICD implantation had higher low-voltage impedance than intermuscular techniques, with an additional 7.82 Ω rise vs FUSIM at 2-5 years.
Synapse has enriched 10 related papers. Consider them for comparative context: